Clover Corporation Limited (CLV) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Clover Corporation Limited.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.470 -- 00:00:05.939 Thank you for standing by and welcome to the Global Corporation Limited 1H 2025 results 00:00:05.939 -- 00:00:08.983 call. All participants are in a listen-only mode. 00:00:08.983 -- 00:00:12.228 There will be a presentation followed by a question and answer session. 00:00:12.228 -- 00:00:16.315 If you wish to ask a question, you will need to press the star key followed by the number 00:00:16.315 -- 00:00:20.842 one on your telephone keypad. I would now like to hand the conference over to Mr. 00:00:20.842 -- 00:00:26.027 Peter Davey, Managing Director and CEO. Please go ahead. 00:00:26.322 -- 00:00:31.370 Good morning. Thank you, Harmony. Welcome to the Clover Corporation first 00:00:31.370 -- 00:00:35.275 half FY25 results presentation. 00:00:35.275 -- 00:00:40.303 My name is Peter Davey, the CEO of the company, and with me is Andrew 00:00:40.303 -- 00:00:45.391 Allibon, the CFO and Company Secretary. Andrew will take you through the financial 00:00:45.391 -- 00:00:47.233 components. 00:00:47.233 -- 00:00:52.484 If we go to the next slide. This is an addition for people that haven't 00:00:52.484 -- 00:00:57.451 known much about us in the past, a bit about the corporation. 00:00:57.451 -- 00:01:02.418 We develop and produce encapsulated bioactive ingredients specialising in high-value 00:01:02.418 -- 00:01:07.385 nutritional oils for infant formula, for medical foods and for functional foods. 00:01:07.385 -- 00:01:10.129 Effectively, what we have is encapsulation technology. 00:01:10.129 -- 00:01:15.456 We take highly valued bioactives and we turn them into powders, 00:01:15.456 -- 00:01:20.557 emulsions and oils that And then those products enable 00:01:20.557 -- 00:01:24.442 our customers to turn them into a finished product. 00:...